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Previous studies have documented that the insulin-producing b-cells of laboratory rodents are coupled by
gap junction channels made solely of the connexin36 (Cx36) protein, and have shown that loss of this protein
desynchronizes b-cells, leading to secretory defects reminiscent of those observed in type 2 diabetes. Since
human islets differ in several respects from those of laboratory rodents, we have now screened human pan-
creas, and islets isolated thereof, for expression of a variety of connexin genes, tested whether the cognate
proteins form functional channels for islet cell exchanges, and assessed whether this expression changes
with b-cell function in islets of control and type 2 diabetics. Here, we show that (i) different connexin isoforms
are differentially distributed in the exocrine and endocrine parts of the human pancreas; (ii) human islets
express at the transcript level different connexin isoforms; (iii) the membrane of b-cells harbors detectable
levels of gap junctions made of Cx36; (iv) this protein is concentrated in lipid raft domains of the b-cell mem-
brane where it forms gap junctions; (v) Cx36 channels allow for the preferential exchange of cationic mole-
cules between human b-cells; (vi) the levels of Cx36 mRNA correlated with the expression of the insulin gene
in the islets of both control and type 2 diabetics. The data show that Cx36 is a native protein of human
pancreatic islets, which mediates the coupling of the insulin-producing b-cells, and contributes to control
b-cell function by modulating gene expression.
INTRODUCTION
Gap junctions are specialized membrane domain concentrating
channels that mediate direct exchanges of cytoplasmic ions
and molecules between adjacent cells (1,2). Gap junction
channels consist of dodecameric assemblies of trans-
membrane proteins called connexins (Cx), which functionally
couple almost all types of vertebrate cells (1,2), including the
main secretory cells of the exocrine and endocrine pancreas
(3,4). In the rodent pancreas, the exocrine acinar cells are
coupled by Cx26 and Cx32, whereas the insulin-secreting
b-cells of pancreatic islets express Cx36, a quite different
connexin isoform (3–5). Accordingly, the connexin-
dependent signaling differently modulates the biosynthesis,
storage and release of specific secretory products in the exo-
crine and endocrine pancreas (3,4).
With regard to Cx36, a large number of in vitro and in vivo
studies converge to indicate an obligatory role in the proper
control of insulin secretion. Thus, single b-cells, which can
no more establish intercellular communication via connexin
channels, show alterations in secretion and insulin gene
expression, which are rapidly corrected after restoration of
b-cell contacts (3–6). These alterations are mimicked by the
acute exposure of either aggregated b-cells, intact islets or
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the entire pancreas to a drug, which blocks connexin channels
(3–7). Further data have shown that the in vitro inhibition of
Cx36 expression (4,8), as well as a large over-expression of
this connexin, significantly perturb the secretion of insulin-
producing b-cells, notably with regard to glucose-induced
insulin secretion (4,8,9). These alterations are because of
loss of the intercellular synchronization, which allows for
the recruitment of increasing numbers of cells into both
insulin biosynthesis and release (10–12), and that is normally
enhanced by natural secretagogues, and particularly glucose
(10,11). Accordingly, mice lacking Cx36 feature an intercellu-
lar desynchronization of glucose-induced [Ca2þ]i oscillations,
which is associated with a loss in the normal pulsatility of
insulin release, with an increased basal release of the
hormone, a nil increase in insulin release in response to
physiologically relevant glucose concentrations, and a
delayed return of b-cells to basal secretion upon the end of
such a stimulation (13–15).
Several alterations observed in Cx36 null mice, including
the loss of oscillatory insulin release, increased basal secretion
of the hormone and loss of response to physiologically rel-
evant glucose concentrations, are reminiscent of the pancreatic
defects reported in either prediabetic human conditions or type
2 diabetes (16–19), raising the question of whether connexin
signaling may also be central to the function of human islet
cells. This question cannot be answered at this time since,
besides the demonstration of gap junctions in human islet
cells (20), no study has yet investigated human islet cells for
the expression of connexins and for the pattern of b-cell coup-
ling that the intercellular channels made by these proteins may
form. This information cannot be merely extrapolated from
studies on rodents, inasmuch as growing evidence indicates
significant structural and functional differences between
human and rodent islets, including the expression of key mem-
brane proteins (21–24). Most importantly, there is still no evi-
dence of whether the expression and/or function of Cx36 is
modulated with the function of human b-cells.
To address these questions, we have explored the human pan-
creas, and specifically its endocrine islets, for the expression of
the numerous connexin genes that have been found in the
human genome (1,2). We have further assessed the expression
of the major endocrine Cx36 protein, and assessed the per-
meability of the functional channels it establishes between
human islet cells. We have eventually compared whether the
expression of Cx36 significantly changes with b-cell function
in the islets of control and type 2 diabetics. We report that
human islets and b-cells express a pattern of Cx36-dependent
coupling similar to that observed in rodents, and that the
expression of this connexin isoform correlates with that of
the insulin gene. Data show that Cx36 is a native protein of
the human b-cell membrane, likely to play a significant role
in the control of insulin production and secretion.
RESULTS
Different connexins are expressed in the exocrine
and endocrine human pancreas
Reverse transcriptase-polymerase chain reaction (RT–PCR)
amplification of total human pancreas RNA revealed abundant
transcripts for Cx32, Cx36, Cx43 and Cx45, lower levels of
Cx31.9 and Cx37 mRNAs and minimal levels of Cx26
mRNA (Fig. 1). In contrast, no transcript was detected for
Cx30, Cx30.3, Cx31, Cx31.1 and Cx40, although the cDNAs
of these connexins were easily detectable using the same
experimental conditions in the tissues (human brain, skin
and heart), which were used as positive controls (Fig. 1).
Using the same approach, transcripts for Cx30.3, Cx31,
Cx31.1, Cx31.9, Cx36, Cx37, Cx43 and Cx45 were also
amplified from human isolated islets (Fig. 1). In contrast, no
transcript for Cx26, Cx30, Cx32 and Cx40 could be amplified
in these samples (Fig. 1).
To determine whether the above-mentioned transcripts actu-
ally resulted in the expression of cognate proteins, we run
western blots of total proteins from either intact pancreas or iso-
lated islets with antibodies targeted to specific connexin iso-
forms. A 25 kDa protein corresponding to Cx26 was detected
in extracts of total pancreas but not of purified islets (Fig. 2A).
A 30–32 kDa protein corresponding to Cx32 was detected in
total pancreas but not islet extracts (Fig. 2B), whereas a
Figure 1. Different connexin transcripts are expressed in the adult human pan-
creas and its endocrine islets. Reverse transcriptase-polymerase chain reaction
revealed the expression of Cx26, Cx31.9, Cx32, Cx36, Cx37, Cx43 and Cx45
mRNAs in intact adult human pancreas, and of Cx30.3, Cx31, Cx31.1, Cx31.9,
Cx36, Cx37, Cx43 and Cx45 mRNAs in the endocrine islets, which were iso-
lated from the gland. In all the experiments, samples of water and of human
liver, brain, skin and heart served as negative and positive controls, respect-
ively. Amplification of the cyclophillin mRNA provided an internal standard.
Human Molecular Genetics, 2009, Vol. 18, No. 3 429
38–43 KDa protein corresponding to Cx43 was detected in both
organs (Fig. 2C). In contrast, antibodies to Cx36 detected a
29–30 kDa band in extracts of purified islets but not total
pancreas (Fig. 2D). These data show that multiple connexins
are expressed in the human pancreas, in a pattern that differs
in the exocrine and endocrine portions of the gland. Thus,
whereas Cx26 and Cx32 are major connexins of the exocrine
region, Cx36 is the prominent connexin of endocrine islets.
Cx36 is expressed by pancreatic b-cells
To evaluate which cell type expressed Cx36 within pancreatic
islets, we first dispersed islet cells, transduced them with a rat
insulin promoter-green fluorescent protein (RIP-GFP) construct
and FACS-purified the GFP-expressing b-cells from the
GFP-negative non-b-cells. Using RT–PCR, we found that the
cells of the GFP-positive fraction expressed Cx36, but no
Cx26, Cx32, Cx43 and Cx45 (Fig. 3A). In contrast, the cells of
the GFP-negative fraction co-expressed Cx43 and Cx36 but no
Cx26, Cx32 and Cx45 (Fig. 3A). These data indicate that islet
b- and non-b-cells express different connexin patterns.
Since these data also indicated that Cx36 may be the only
connexin expressed by pancreatic b-cells, we immunostained
the protein in sections of control human pancreas. Using
peroxidase-conjugated antibodies, modest levels of the con-
nexin were observed in most of the cells making the islets
(Fig. 3B). The staining had the characteristics of specificity,
inasmuch as it was not seen when the sections were incubated
with a pre-immune serum and, in the presence of antibodies to
Cx36, was restricted to cells containing insulin, and absent in
islet cells lacking the hormone, as well as in the islet vessels
(Fig. 3B). Using fluorochrome-tagged antibodies, most Cx36
was shown to be distributed in small, discrete spots, all
along the membrane of the insulin-containing b-cells
(Fig. 3C). These data show that, in the human pancreas,
Cx36 is selectively expressed by differentiated b-cells.
b-Cells form Cx36 gap junctions in selected domains
of their membrane
To ascertain the insertion of Cx36 into b-cell membranes, we
immunolabelled the protein in western blots of total extracts
and purified membranes of isolated pancreatic islets. Cx36
was detected in the two fractions at comparable levels
(Fig. 4A). However, whereas a single band was labelled in
total cell extracts, two bands were stained by the antibodies
against Cx36 in the purified membrane fraction (Fig. 4A).
To specify the membrane domain containing Cx36, a cold
lysate of human islets was subjected to a discontinuous
sucrose density gradient centrifugation. We observed that
most Cx36 was contained in fractions 4–7, which were
enriched in lipid rafts as judged by the presence of the ganglio-
side GM1 marker (Fig. 4B). In contrast, only minimal amounts
of Cx36 were found from fraction 8 (Fig. 4B) onwards, which
contained marker proteins of the Golgi apparatus, lysosomes
and mitochondria. Comparable observations were made con-
cerning Cx43 (Supplementary Material, Fig. S1).
To assess whether the Cx36 inserted into b-cell membranes
properly packed into gap junction plaques, freshly isolated
human islets were processed for freeze-fracture electron
microscopy. Analysis of the membrane of islet cells contain-
ing numerous secretory granules, revealed the presence of
typical trans-membrane connexin aggregates (Fig. 4C),
whose spotted distribution was consistent with that of the
Cx36 immunofluorescence labeling. In most cases, these
plaques were tightly intermingled with the fibrils of focal
tight junctions (Fig. 4C). These data show that Cx36 is
inserted into selected domains of the b-cell membrane, pre-
sumably lipid rafts, where it forms gap junction plaques.
Human b-cells are coupled by Cx36 channels
To assess whether the Cx36 expressed at the membrane of
b-cells formed functional cell-to-cell channels, individual
Figure 2. The major pancreatic connexins are differentially expressed in the
exocrine and endocrine portions of the human gland (A–C). Western blots
detected Cx26 (A) in extracts of total pancreas but not of purified islets. A
faint 32 kDa band, corresponding to Cx32, was also detected in total pancreas,
but not isolated islets (B). Cx43 (C) were found in both total pancreas and islet
extracts. (D) In contrast, antibodies detected Cx36 in extracts of purified islets
but not total pancreas. More Cx36 was detected in highly purified (90%) than
in poorly purified islets (70%). Twenty micrograms of protein were loaded
per lane. Immunolabeling ofa-smooth muscle actin served as loading reference.
Extracts of human liver and heart, as well as of the insulin-producing MIN6 cells
served as positive and negative controls, depending on the connexin isoform.
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cells of human islets freshly isolated from normoglycemic,
multi-organ cadaveric donors were microinjected with either
Lucifer Yellow (LY) or Ethidium Bromide (EB), two tracers
that do not permeate the membrane of living cells. In approxi-
mately 76% of the cases, this microinjection resulted in the
diffusion of the tracer from the injected cell into some of its
neighbors, whether LY or EB was used (Fig. 5A). On the
average, however, LY revealed a smaller (P , 0.001) inter-
cellular diffusion than EB, corresponding to an estimated
number of 1.4+0.2 (n¼ 25) and 5.8+0.9 (n¼ 25) cells,
respectively (Fig. 5B), as expected for junctional channels
made of Cx36. Analogous observations were made in the
islets of the single type 2 diabetic donor that we could study
immediately after isolation (data not shown). The data document
that Cx36 forms functional channels between adjacent islet cells.
The expression of Cx36 parallels that of the insulin gene
To evaluate whether the expression of Cx36 changes with
b-cell function, total RNA was obtained from islets freshly
isolated from multi-organ cadaveric donors that were either
normoglycemic and without a history of overt diabetes (n ¼
10) or that were known to be type 2 diabetics (n ¼ 11). Clini-
cal information on these individuals is given in the Materials
and Methods section. Quantitative PCR (qPCR) revealed
that, relative to the levels of cyclophilin mRNA, the levels
of Cx36 mRNA varied widely in both the control and the dia-
betic samples (Fig. 6), which we obtained from co-authors in
Pisa and Philadelphia, preventing a reliable assessment of any
difference between the healthy and the diseased group of
patients. Strikingly, however, the expression of the Cx36
Figure 3. Cx36 is expressed by pancreatic b-cells. (A) Reverse transcriptase-polymerase chain reaction (RT–PCR) amplification of total RNA showed
expression of Cx36 in FACS-purified and green fluorescence protein (GFP)-expressing human b-cells, and of both Cx36 and Cx43 in the GFP-negative
non-b-cells. Neither fraction expressed Cx26, Cx32 and Cx45. Because of the high sensitivity of the non-quantitative RT–PCR approach, some insulin transcript
was detected in both cell fractions, owing to the unavoidable contamination of the non-b-cell fraction by a limited number of small size b-cells. (B) Immunoper-
oxidase staining of a section of a control human pancreas showed that several cells containing abundant insulin (left panel) also expressed significantly lower
levels of Cx36, whereas islet cells lacking detectable immunolabeling for insulin (solid arrows) as well as cells of islet vessels (open arrow) lacked Cx36 (middle
panel). No islet cell was stained after incubation with non-immune IgGs (right panel). Bar, 50 mm. (C) Immunofluorescence showed that most Cx36 was dis-
tributed as small, discrete spots (green; middle panel) all along the membrane of the insulin-containing b-cells (red; left panel). The right panel is the merge of
the left and middle panels showing the location of Cx36 in b-cells (yellow). Bar, 30 mm.
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gene was found to be significantly correlated (r2 ¼ 0.834, P ,
0.001, n ¼ 21) with that of the insulin gene, in both the control
(r2 ¼ 0.745, P , 0.01, n ¼ 10) and the diabetic group (r2 ¼
0.871, P , 0.001, n ¼ 11) (Fig. 6). The data show that Cx36
is expressed by both normo- and hyperglycemic individuals,
in a pattern that varies with b-cell function, and is interdepen-
dent on the expression of insulin.
DISCUSSION
We have investigated the pattern of connexins expressed in the
human pancreas, with a special focus on the endocrine portion
of the gland. We show that Cx36 mRNA, and much lower
levels of several other connexin transcripts, are selectively
expressed in the endocrine pancreatic islets, whereas Cx26
and Cx32 mRNAs are expressed in the exocrine pancreatic
Figure 4. b-Cells form Cx36 gap junctions in lipid rafts of their membrane. (A) Western blots detected Cx36 in extracts of both purified islet cell membrane (m)
and total isolated islets (T), but not in extracts of total pancreas. Forty micrograms of protein were loaded per lane. Immunolabeling of a-smooth muscle actin
served as loading reference. Extracts of wild type (RIN2A) and Cx36-transfected RIN2A insulin-producing cells (RIN36) served as negative and positive con-
trols, respectively. (B) Discontinuous sucrose density gradient centrifugation of a Triton X-100 lysate of human islets showed that most Cx36 (middle panel) was
recovered in fractions of 4–7, which were enriched in lipid rafts as judged by the presence of the GM1 ganglioside (top panel). The bottom panel shows the
western blot with an antibody against Cx36. Fraction 2 ¼ 35% sucrose; fraction 8 ¼ 5% sucrose. (C) Freeze-fracture electron microscopy showed that b-cell
membranes contained typical gap junction plaques (arrow heads) made of connexin oligomers, that in most cases were found tightly associated to tight junctions
(arrows). The presence of connexin particles on the P fracture face of one membrane (left panel) and of corresponding pits on the E fracture face of the adjacent
membrane (right panel) demonstrates the trans-membrane disposition of the connexin channels. Bar, 120 nm.
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acini. Accordingly, we document a differential distribution of
the cognate proteins in the two regions of the gland. These
data show that the most abundant connexins of the human
pancreas are expressed in a pattern comparable to that pre-
viously reported in laboratory rodents, supporting the view
that different forms of connexin channels and signaling are
required for the normal function of the endocrine and exocrine
pancreas (3–5,24,25–29). Specifically, they show that, in con-
trast to a previous report (30) that contrasted with a number of
observations in rodents (3–5,24,25–27), Cx26 is not detected
in human pancreatic islets.
With regard to Cx36, which was the main focus of this
study, our data show that it is the prominent connexin of
human insulin-producing b-cells, as seen in rodents (3–
5,8,13,15,25,28). Here, we provide evidence that Cx36 is
concentrated at gap junction plaques closely linked to tight
junctions, within Triton-insoluble and sphingolipid-enriched
domains of the b-cell membrane. These data are consistent
with the previous observations in other systems, documenting
that both connexins and tight junction proteins are targeted to
lipid rafts (31–33). The reason(s) for this selective localization
remain(s) to be fully understood. Several proteins which play
important roles in insulin secretion, including Kv2.1, calmodu-
lin, SNARE proteins, kinases and phosphatases, are localized
in lipid rafts (34,35). The present finding that Cx36 is also con-
centrated in a similar environment, suggests that the mechan-
ism whereby this connexin plays a significant role in the
regulation of b-cell function (8,13–15), may involve inter-
actions with the proteins (4,5,20,36,37) and/or lipids that are
segregated in these selected membrane domains (38).
Whether the control of Cx36 channels is affected by their
lipid environment, as is the case for other connexins (38),
remains to be established. Consistent with this idea, b-cells
can be rapidly and reversibly uncoupled by lipophilic drugs
(7,29), whose uncoupling efficiency parallels their lipid parti-
tioning (39). The different membrane environment of Cx36 in
different cell types may also account for the observation that
the channels made by Cx36 between rodent b-cells are
alike, though not identical to those which the same protein
makes between neurons (40), notably with regard to the sensi-
tivity to quinine-induced blockade, or HeLa cells, notably with
regard to ethidium bromide permeability (41).
Our study provides the first functional evidence that the
Cx36 expressed at the membrane of human b-cells forms
bona fide junctional channels, coupling most, though not all
adjacent islet cells, as indicated by the rapid cell-to-cell trans-
fer of different tracers that cannot permeate the cell membrane
(42,43). Within the second-to-minute time-course of our
microinjection experiments, we have observed that this coup-
ling is limited to small communication territories that rep-
resent but a fraction of individual human islets. This pattern
cannot be solely attributed to the patchy arrangement of
b-cell clusters and/or to the high proportion of non-b-cells
within the human islet (21), inasmuch as it was also observed
after microinjection of rodent islets and monolayer cultures of
transformed insulin-producing cells (4,7,9,13,14). As in these
cases, the positively charged ethidium bromide revealed a sig-
nificantly larger coupling of human b-cells (typically, six to
seven cells were shown to be coupled using this tracer,
Figure 5. Human b-cells are coupled by Cx36 channels. (A) Microinjection of
Lucifer Yellow into individual cells of freshly isolated human islets resulted in
the diffusion of the tracer from the injected cell into some of its neighbors
(yellow; left panel). A much larger intercellular diffusion was observed
when another b-cell of the very same islet was microinjected with ethidium
bromide (red; right panel) Bar, 25 mm. (B) Quantitative analysis showed
that the average extent of b-cell coupling revealed by the small and positively
charged ethidium bromide (solid bar) was three- to four-fold larger than that
revealed by the larger size and negatively charged Lucifer Yellow (open
bar). P , 0.001 versus ethidium bromide diffusion. Values within
columns are number of microinjections.
Figure 6. The expression of Cx36 in human b-cells parallels that of the insulin
gene. Quantitative PCR amplification of total RNA extracted from isolated
islets of normoglycemic (open symbols) and type 2 diabetics (solid
symbols) revealed a quantitatively variable expression of Cx36 in all
samples. The expression levels of the connexin were significantly correlated
(r2 ¼ 0.834, P , 0.001, n ¼ 21) with those of the insulin gene. Cx36 and
insulin mRNAs were expressed relative to the levels of cyclophillin.
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which is consistent with the size of the patchy clusters of
different islet cell types within the human islets) than the nega-
tively charged LY. In spite of a molecular weight close to that
of ethidium bromide, this tracer revealed coupling between
only one and two islet cells in both rodents (4,7,9,13,14) and
human islets (this study), presumably because of the cationic
permselectivity of Cx36 channels (9,41,42), the small macro-
scopic conductance of gap junctions at b-cell interfaces
(15,43–46), and the hydrated size of the LY molecule,
which approximates the functional bore of individual connexin
channels (42). Because of these conditions, the limited coup-
ling of b-cells, which is sufficient and obligatory to account
for the physiologically relevant intercellular synchronization
and propagation of electrical currents and Ca2þ waves
(8,13,15,45–47), may escape detection when tested with nega-
tively charged tracers at the periphery of rodent islets (48),
where adjacent b-cells are rare, after culture of clusters of
islet cells (48) or isolated islets (46) that could rapidly
decrease the levels of the short-lived connexins (8,49) or at
a sub-physiological temperature (46), which would decrease
the motion of the tracers in the cytosol. At any rate, the
finding that ethidium bromide revealed a significantly larger
coupling of human b-cells than LY, rules out a significant
functional contribution of other types of b-to-b-cell channels
made by a different connexin isoform, that typically are
much more permeable to negatively charged tracers than the
channels made by Cx36 (4,9,28,42). In turn, this consideration
raises questions about the reported expression of Cx26 in
human pancreatic islets (30), which we could not confirm in
our study, and that should have provided an extensive coup-
ling when assessed with LY (27,42,50,51). It also rules out
the potential participation to b-cell coupling of several other
connexin isoforms, including Cx31.1, Cx37 and Cx31.9,
which have not been investigated in the rodent pancreas,
and whose transcripts we have found expressed, at levels
significantly lower than those of Cx36, in human islets. By
analogy with a number of other cell systems in which the
cellular distribution of the corresponding proteins has been
determined, it is plausible that these connexins are expressed
by the cells of the vessels and connective tissue of the
human islets (25,52). Strikingly, we could not detect in the
pancreas and isolated islets we studied a transcript for Cx40,
a connexin which couples many types of endothelial cells in
several, but not all regions of the vascular system (52).
Given that other bona fide ‘vascular’ connexins (e.g. Cx37,
Cx43 and Cx45) were easily identified by the same methods
in the very same samples, the simplest explanation is that
islet vessels may not express Cx40 at detectable levels.
These data now call for future investigations on the actual
protein expression and possible function of these minoritary
connexins, which may be relevant to the integrated function-
ing of pancreatic islets. Still, our molecular biology, bio-
chemical, morphological and functional findings converge to
show that the functional exchanges of cytosolic molecules
between human b-cells are solely due to Cx36, the protein
which was actually shown to be obligatory for the electrical
and dye-coupling of rodent b-cells (4,8,13–15).
The conservation of Cx36 distribution and coupling organ-
ization in rodent and human islets, in spite of several major
structural and functional differences, including the number
and arrangement of b-cells, their Ca2þ handling and their
equipment in ion channels (21–24) supports the view that
Cx36 plays an indispensable role in b-cell function. In
rodent islets, Cx36 is essential to synchronize across small
groups of cells the oscillatory changes in Ca2þ and currents
that are induced by glucose stimulation (8,15), and which, in
turn, control the normal pulsatility of insulin release from indi-
vidual islets (13). Human b-cells also display Ca2þ oscil-
lations under glucose stimulation, although the intercellular
synchronization of these events may be more limited than in
rodents, presumably because b- and a-cells are intermingled
within human islets (21). Whether Cx36 plays any role in
the Ca2þ and current handling of human b-cells in such an
environment awaits the possibility to modulate the levels of
the protein within human islets. If technically feasible, this
approach is presently complicated by the difficulty to obtain
large numbers of human islets for research purposes (53).
Thus, to test whether Cx36 plays a significant role in the func-
tion of human b-cells, we have analyzed by qPCR the levels of
Cx36 and insulin transcripts in total RNA extracted from islets
of either control individuals or type 2 diabetic patients. In spite
of a large variability in expression, we have found that the
levels of these two transcripts were highly and directly corre-
lated in both the normoglycemic and the hyperglycemic indi-
viduals. This finding shows a parallel, hitherto unsuspected
control of the Cx36 and the insulin genes, that is presumably
accounted for by the regulation of the cognate promoters using
a similar set of transcription factors. It also adds the insulin
gene to the growing list of genes whose expression is coordi-
nately controlled with that of Cx36 (54), pointing that control
of gene expression is a relevant mechanism whereby connex-
ins may affect cell function (50,54). This is the first evidence
that this also applies for Cx36 in humans. Given the primordial
importance of insulin expression for the identity and proper
function of pancreatic b-cells, our data also provide the first
evidence that Cx36 is one of the factors that are relevant for
the functional control of human b-cells (55).
Previous experimental studies in rodents, have documented
that loss of this connexin results in alterations of insulin
secretion that are reminiscent of the main characteristics of
prediabetic states and type 2 diabetes (8,13,15). Strikingly,
the human GJD2 gene that codes for Cx36 (http://www.gene-
names.org/genefamily/gj.php) is located on chromosome
15q14 (56), a region of the genome which has also been
linked to type 2 diabetes in various populations (57–60).
Thus, if the effects observed in rodents were to be extended
to humans, type 2 diabetic patients would be anticipated to
express lower levels of the Cx36 protein and/or decreased
b-cell coupling than normoglycemic individuals (61). We
found a large variability in the levels of the Cx36 transcript in
both the control and the diabetic individuals that, within the
limits of our small sample, could not be attributed to a specific
difference in clinical phenotype, and prevented an unambigu-
ous conclusion to be drawn with regard to the amounts of
Cx36. On the other hand, our experiments show that at least
some coupling is retained between the b-cells of type 2
diabetics, in agreement with the findings made in cell and
animal models exposed to high glucose and/or fatty acids
(62–64), suggesting that the diabetes-related Cx36 defect, if
any, is likely to be quantitative rather than qualitative.
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In summary, our data document that the connexin pattern of
the human pancreas is similar to that previously described in
rodents, notably with regard to the prominent expression of
Cx36 in the insulin-producing b-cells. We show here that
this protein concentrates at gap junction plaques within
specific domains of the islet cell membranes, and forms junc-
tional channels that are permeated by various molecules, still
favor the b-to-b-cell exchange of cationic species. We even-
tually document that the expression of the Cx36 and the
insulin genes are correlated. Thus, Cx36 may significantly
contribute to modulate the function of human b-cells.
MATERIALS AND METHODS
Tissues, islets and sorted b-cells
Samples of control human liver, heart, skin, brain and pan-
creas were obtained from surgical specimens taken for diagno-
sis purposes at the Department of Pathology, University
Hospital of Geneva, with the informed consent of the
patient, and according to the rules of our institutional ethics
committee for research on human beings.
Human islets from cadaveric multi-organ donors were iso-
lated at the Cell Isolation and Transplantation Center of our
institution. Briefly, pancreases harvested from multi-organ
cadaveric donors were processed using a previously described
modification (65) of the automated method (66). Aliquots of
20,000 islets were incubated in 30 ml CMRL 1066 medium
(Sigma, St Louis, MO, USA) containing 5.6 mM glucose
supplemented with 10% fetal calf serum (FCS), 25 mM
N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid
(HEPES), 2 mM glutamine, 100 U/ml penicillin and 100 mg/
ml streptomycin (hereafter, referred to as complete CMRL).
In most experiments, the islets were cultured 1–3 days
before collection and analysis. For dye-coupling experiments,
a few isolated islets were studied immediately after isolation.
Human islets from 11 type 2 diabetic and 10 normoglycemic
cadaveric donors without a history of the disease, to be ana-
lyzed by real-time qPCR, were isolated from the co-authors
in Pisa (67) and Philadelphia. The control (six males and
four females) and diabetic individuals (eight males and three
females) had overlapping ages (40–72 and 33–79 years in
the control and diabetic groups, respectively) and body mass
index values (18–35 and 24–50 in the control and diabetic
groups, respectively; NS) in the two groups. At the time of
pancreas harvesting, diabetic and non-diabetic donors had
blood glucose levels of 275+ 13 mg/dl (n ¼ 11) and 164+
9 mg/dl (n ¼ 10, P, 0.001), respectively.
To purify b-cells, the isolated islets were dissociated by
incubation at room temperature in 2 ml of enzyme-free ‘dis-
sociation buffer’ (Sigma), under frequent pipetting. The reac-
tion was stopped with the addition of F10 medium (Gibco)
containing 5% (v/v) FCS, 1% (w/v) bovine serum albumin
(BSA) and 7.5 mM glucose (F10/FCS/BSA). Aliquots of
2  106 primary islet cells were infected with 2  108 pfu
recombinant and replication-defective adenovirus expressing
GFP under control of the rat insulin I promoter (Ad-RIP-GFP)
for 2 h at 378C, washed two times in F10/FCS/BSA and cul-
tured in this medium for 48 h (68). At this time, the infected
cells were dispersed with 0.025% trypsin and 0.3 mM EDTA,
washed and resuspended in Krebs-Ringer bicarbonate buffer
(KRBB) containing 10 mM Hepes, 8.3 mM glucose and 0.5%
BSA (KRBB–BSA). GFP-positive b-cells were sorted from
non-fluorescent islet cells using a FACStar-Plus machine
(Becton-Dickinson), equipped with an argon laser beam
tuned to 488 nm (68). Non-infected cells served as controls.
Cx mRNA
Total RNA was extracted from tissues as previously described
(5), and reverse-transcribed for 50 min at 428C, using 200 U
superscript II Moloney murine leukemia virus reverse tran-
scriptase in 50 mM Tris–HCl buffer (pH 8.3), supplemented
with 75 mM KCl, 3 mM MgCl2, 10 mM dithiothreitol, 0.5 mM
4dNTP and 61.5 ng/ml Random Hexamer (all reagents from
Gibco, BRL). Total RNA from b- and non-b-cells was iso-
lated using the QIAGEN RNeasy Mini kit (Qiagen, Santa
Clara, CA, USA), denatured at 658C for 5 min and reverse-
transcribed for 60 min at 378C using a SensiscriptTM
reverse transcriptase (Qiagen), primed with 61.5 ng/ml
Random Hexamers (Gibco BRL).
All cDNA samples were incubated for 20 min at 378C in the
presence of 0.5 U RNAseH. Amplification of the resulting
cDNAs was performed in a final volume of 50 ml by adding
5 ml amplification buffer containing 100 mM Tris–HCl (pH
8.8), supplemented with 500 mM KCl, 15 mM MgCl2, 1%
Triton X-100, 0.6 ml 10 mM 4dNTP (Gibco BRL), 1 U Dyna-
zyme (Finnzymes) and 0.167 mM of the following sense and
antisense primers:
Cx isoform Sense primer Antisense primer
Cx26 TCCCCATCTCCCACATCCGGC AAGATGACCCGGAAGAAGAT
Cx30 GGGAAGGTGTGGATCACAGT AAGCAGCATGCAAATCACAG
Cx30.3 CCTGTACGACAACCTGAGCA GATACCCACCTGCATCCACT
Cx31 TATACGTGGTGGCTGCAGAG AGGCTGAACAGGTAGGTCCA
Cx31.1 CACAAGGACTTCGACTGCAA GCTTGGAGATGAAGCAGTCC
Cx31.9 GCCTTCCCGGTCTCCCACTAC GAGCAGCTTCTGCGCCTCTTC
Cx32 GGGAGGTGTGAATGAGGCAG GGTGGATTGGAGCGGCGCTGG
Cx36 AACGCCGCTACTCTACAGTCTTCC GATGCCTTCCTGCCTTCTGAGCTT
Cx37 GGCTGGACCATGGAGCCCGT AGGGGGCAGGGGGCATCCCA
Cx40 GGGCGATTGGAGCTTCCTGGG TTAAAGTCGGGGGGTGGTGT
Cx43 GCAACATGGGTGACGGAGCG GCCAGGTACAAGAGTGTGGGT
Cx45 CTCCCATGTACGCTTCTGG CGGGTGGACTTGGAAGCCA
Cyclophilin GGTCAACCCCACCGTGTTCT TGCCATCCAGCCACTCAGTCT
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After a 5 min start at 948C, the amplification was carried out
in a PCR T3 machine (Biometra) for 30 cycles, each compris-
ing 1 min at 948C, 1 min at either 528C (for Cx30, Cx30.3,
Cx31 and Cx31.1), 558C (for Cx32, Cx36, Cx43 and Cx45),
588C (for Cx26 and cyclophilin) or 608C (for Cx31.9, Cx37
and Cx40), and 1 min at 728C. A final cycle comprised of
5 min at 728C. Aliquots (10 ml each) of the amplified DNA
fragment were separated on a 2% agarose gel and stained
with 0.5 mg/ml ethidium bromide (5). Samples of human
heart, liver, skin and brain served as positive and negative con-
trols for the various connexins.
For qPCR analysis of Cx36 transcripts in the islets of
control and type 2 diabetic individuals, total RNA extracted
from human islets was purified using the Qiagen RNeasy
mini kit and 0.5 mg were reverse-transcribed into cDNA.
The following sense and antisense primers were designed
using the Primer Express Software (Applera Europe, Rotkreuz,
Switzerland): for Cx36, 50-AAGGCATCTCCCGCTTC
TACA-30 and 50-GCCAACCAGGAACCCAATTT-30, for
cyclophillin, 50-TACGGGTCCTGGCATCTTGT-30 and
50-CCATTTGTGTTGGGTCCAGC-30. The qPCR was per-
formed in an ABI 7000 Sequence Detection System
(Applera Europe) and PCR products were quantified using
the SYBR Green Core Reagent kit (69). Two independent
amplifications of each sample were performed and each tran-
script evaluated in duplicates. Mean values were normalized to
the mean value of the reference mRNA cyclophilin (69). Auth-
enticity of each amplicon was verified by DNA sequencing.
Cx proteins
Total protein extracts were prepared by homogenization of
human tissues and isolated islets in a 0.1 M Tris–HCl buffer,
pH 7.4, supplemented with 5 mM EDTA, 5% SDS, 1 mg/ml
pepstatin A, 1 mg/ml antipain, 1 mM benzamidine, 200 Kin/ml
aprotinin, 2 mM phenylmethanesulphonylfluoride (PMSF) and
1 mM DFP, followed by sonication (5). After a 10 min centri-
fugation of the sonicate at 16,000g and 48C, the supernatant
was collected and stored at 2208C.
Protein content of all the samples was measured by the DC
protein assay kit (Bio-Rad Laboratories). Samples of total
proteins (20–40 mg protein/lane) were separated by electro-
phoresis in either 12% (Cx26 and Cx32) or 10% (Cx36 and
Cx43) polyacrylamide gels. Electrophoresed samples were
transferred onto PVDF membranes (ImmobilonTM-P, Milli-
pore) in the presence of 0.01% SDS and 20% methanol,
using a constant current of 400 mA for 2 h. The membranes
were saturated for 30 min at room temperature in a 10 mM
Tris–HCl buffer (pH 7.4) containing 150 mM NaCl, 0.1%
Tween 20 (TBS-Tween) and 5% dry milk, and then incubated
overnight at 48C with one of the following antibodies: for
Cx26, mouse monoclonal antibody clone CX-12H10 (Zymed
Laboratories, San Francisco, CA, USA) diluted 1:500; for
Cx43, mouse monoclonal antibody clone CX-1B1 or rabbit
polyclonal antibody 71–0700 (Zymed Laboratories) diluted
1:500 and 1:100, respectively; for Cx32, affinity-purified anti-
serum 26KAP (courtesy of K. Willecke) diluted 1:1000. For
Cx36 immunoblots, the electrophoresed samples were trans-
ferred onto nitrocellulose membranes (Hybond ECL, Amer-
sham Biosciences) in the presence of 0.04% SDS and 20%
methanol, using a constant current of 250 mA for 1 h. After
the initial experiments with PVDF membranes, we noticed
that nitrocellulose membranes resulted in higher signals and
lower background for most connexin immunolabelings. We
therefore opted for nitrocellulose membranes for all the
remaining experiments. The membranes were rapidly
washed in 10 mM Tris–HCl buffer (pH 7.4) containing
150 mM NaCl, 0.4% Tween 20 (TBS-Tween) and 5% dry
milk and then incubated with one of the following antibodies:
for Cx36, rabbit polyclonal (5), diluted 1:1000 and used over-
night at 48C; for smooth muscle actin, rabbit polyclonal anti-
body A2066 (Sigma Chemical Co) diluted 1:1000 and used 2 h
at room temperature; for a1-anti-trypsin rabbit polyclonal
antibody A0012 (Dako), diluted 1:2000 and used for 2 h at
room temperature. After repeated rinsing in TBS-Tween, the
immunoblots were incubated for 60 min at room temperature
with a goat anti-rabbit or anti-mouse Igs, whichever appropri-
ate, conjugated to horseradish peroxidase (Bio-Rad Labora-
tories) and diluted 1:6000. Membranes were then washed
and developed by enhanced chemiluminescence, according
to manufacturer’s instructions (Amersham Pharmacia
Biotech). In all blots, the amount of loaded protein was con-
trolled by probing the very same filters with the polyclonal
antibody mentioned above. All blots included, as a positive
control, extracts from RIN-2A cells transfected for Cx36 (9).
Cx in islet cell membranes
To prepare protein extracts of membranes, human tissues and
isolated islets were homogenized by sonication in 0.1 M Tris–
HCl buffer, pH 7.4, supplemented with 20 mM EDTA, 1 mg/ml
pepstatin A, 1 mg/ml antipain, 1 mM benzamidine, 200 Kin/ml
aprotinin, 2 mM PMSF and 1 mM DFP. After a 10 min centrifu-
gation of the sonicate at 900g and 48C, the supernatant was
collected and centrifuged 60 min at 100,000g and 48C (70).
Pelleted material was resuspended (for storage at 2208C) in
50 mM Tris–HCl buffer, pH 7.4, supplemented with 120 mM
NaCl, 1 mM CaCl2, 3 mM MgCl2, the abovementioned concen-
trations of protease and phosphatase inhibitors (70), and
containing 1% Triton X-100. The addition of this non-ionic
detergent is known to promote the enrichment of both lipid
rafts (71,72) and gap junction plaques (73).
Raft fractions of islet membranes, identified by enrichment
of the GM1 ganglioside, were prepared by sucrose density gra-
dient centrifugation, as previously described (71). To this end,
aliquots of 20,000 human islet equivalents were collected by
centrifugation, rinsed in PBS and lysed for 30 min on ice, in
100 ml TNE/Triton X-100 buffer (25 mM Tris–HCl, pH 7.4,
containing 5 mM EDTA, 150 mM NaCl and 1% TX-100),
supplemented with protease inhibitors (Roche). The samples
were mixed with 162 ml 73% sucrose in Tris-KCl-MgCl2
(TKM), to reach a final 40% (w/v) sucrose concentration and
transferred to a 2.2 ml ultracentrifuge tube. A discontinuous
sucrose density gradient was made by layering 1.2 ml 35%
sucrose, and then 0.7 ml 5% sucrose (all solutions in TKM
buffer). The gradients were centrifuged for 18–21 h at
258,800g (55,000 rpm in a S55S Sorval rotor) and 48C. Ten
200 ml fractions were collected from the bottom of the tubes.
The GM1 distribution was assessed in dot blots of 6 ml
samples of each fraction, using CTxB-HRP. The distribution
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of Cx36 and a1-anti-trypsin (74) were analyzed in each fraction
by immunoblotting with the specific antibodies mentioned
above. To this end, trichloroacetic acid was added to each frac-
tion to a final concentration of 9%, the samples were incubated
30 min on ice, and centrifuged 10 min at 12,000g and 48C. The
resulting pellets were washed with 1 ml 2208C acetone and
air-dried. Pelleted material was resuspended in 10 mM Tris–
HCl buffer, pH 7.4, supplemented with 0.5% deoxycholate
and 0.5% Nonidet P40 (NP40), and stored at 2208C.
For in situ immunolabeling of b-cells, fresh surgical
samples of two human adult pancreas (from a 20- and a
56-year-old individual) were embedded in OCT (Sigma),
frozen and stored at 2808C. Cryosections of 8 mm were cut
and used immediately for staining. Sections were allowed to
reach room temperature, dried for 1 h, fixed for 5 min with
2% PFA in PBS, permeabilized for 10 min at room tempera-
ture with 0.1% Triton-X100, and blocked for 10 min with
50 mM Glycin in PBS. The sections were incubated for 1 h
in PBS (pH ¼ 7.4) containing 1% BSA, 2% donkey serum
and 1% cold water fish gelatin, and then 2 h with one of the
following antibodies: sheep anti-human (The Binding Site)
and rabbit anti-Cx-36 (C7855-14; US Biological). After
rinsing, the sections were reacted for 1 h at room temperature
with either Lissamine–Rhodamine-labeled donkey F(ab)2
against rabbit immunoglobulins (Igs) or fluorescein
isothiocyanate-labeled donkey F(ab)2 against sheep Igs (both
antibodies preadsorbed on multiple species serum proteins;
Jackson ImmunoResearch), or with sera from the same
species conjugated to peroxidase (75). Stained sections were
mounted and viewed on a FV-1000 confocal microscope
(Olympus). Controls included exposure of the islet sections
to only the secondary appropriate antibody. None of these
incubations resulted in a sizable, specific staining of the sec-
tions.
For ultrastructural assessment of gap junction plaques, iso-
lated islets were fixed for 1 h in a 2.5% glutaraldehyde
solution in 0.1 M phosphate buffer, infiltrated with 30%
glycerol, frozen in vacuum-solidified liquid nitrogen, and pro-
cessed for freeze-fracture using a BAF060 Freeze Etching
System (BAL-TEC, Liechtenstein), as described (76). Repli-
cas were screened, under a Philips CM10 electron microscope.
Islet cell coupling
Human islets freshly isolated at the Cell Isolation and Trans-
plantation Center of the University of Geneva were attached
to Sylgardw- and poly-L-lysine-coated dishes and transferred
onto the heated (378C) stage of a Universal microscope
(Zeiss). Individual cells were microinjected for 5 min using
glass electrode pulled to a resistance of 50–60 MV, as
assessed in 150 mM LiCl, and whose tip was filled with
either 4% (w/v) LY CH or 1% (w/v) ethidium bromide
(both tracers from Sigma) dissolved in 150 mM LiCl buffered
to pH 7.2 with 10 mM HEPES (7,9,13,14). After back-filling of
the electrode shaft with 3 M HEPES-buffered LiCl, the electro-
des were used to penetrate individual cells located deep in the
islet core. Following successful penetration, the tracers were
iontophoretically injected for 10 min, by applying square
pulses of 0.5 nA amplitude, 900 ms duration and 0.5 Hz fre-
quency of negative (LY) or positive polarity (ethidium
bromide). At the end of each experiment, the dark-field and
epifluorescence views of the injected field were immediately
recorded before and/or after pulling out the electrode, using
an AxioCam digital camera (Zeiss, Jena, Germany) and set-
tings for FITC or rhodamine fluorescence, whichever appro-
priate (9,41). Cell-to-cell coupling was defined as the tracer
diffusion from the injected cell to at least one of its immedi-
ately adjacent neighbor. Uncoupling was defined as the per-
sistence of the tracer in only the microinjected cell. The
incidence of coupling was determined by scoring the number
of microinjections that resulted in the cell-to-cell transfer of
the tracers, as determined by inspection of the islets immedi-
ately at the end of each microinjection (9,41). The extent of
coupling was determined by measuring the area of cells
stained by the tracers, using a digitalizing tablet and the Lei-
caQWin software (Leica, Wetzlar, Germany). The number of
coupled cells was estimated by dividing this area by the calcu-
lated average surface of a single b-cell profile (approximately
450 mm2).
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